Cascade ProDrug

Cascade Prodrug, Incorporated is an advanced pharmaceutical company developing targeted prodrug therapies for the treatment of hyperproliferative diseases. The company’s initial focus is on prodrugs activated under abnormally low oxygen concentrations (tumor hypoxia) found in most solid tumors. By selectively targeting tumor hypoxia activation, the company’s prodrugs exhibit lower toxicity to normal cells, offering safer and more effective cancer treatments.